Although Afrezza isn’t officially approved for use with AID systems, Dr. Edelman and Dr. Pettus use it all the time, and they prescribe it to many of their patients who are on pumps. Learn how inhaled insulin can be a compliment to AID systems, when it works best, and when you need to be cautious.
[read_more text="read more" title="read more" url="https://tcoyd.org/2026/01/afrezza-with-aid-systems/" align="left"]
2026 is gearing up to be another milestone year in diabetes innovations. From continuous ketone monitoring to once-weekly insulin and new GLP-1 combinations like the “Triple G”, it should be an exciting year! Here are the biggest advancements coming down the pike.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/12/diabetes-predictions-2026/" align="left"]
Wayne was diagnosed in the “dark ages” of type 2 diabetes when there were only two treatment options available. His 40-year journey with T2D shows how staying curious and being proactive can turn an overwhelming diagnosis into a decades-long success story.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/11/secret-to-managing-type-2-diabetes/" align="left"]
Flu season is here, but if you have diabetes, those body aches or stomach troubles might not be the flu at all – they could be signs of diabetic ketoacidosis (DKA). Because DKA can look a lot like the flu, it’s easy to miss the red flags until it’s too late. Here’s how to spot the difference.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/10/dka-vs-flu-symptoms/" align="left"]
If you’ve ever been told you need more medication, a higher dose of medication, or insulin, it’s not because you failed at managing type 2 diabetes. Learn about the natural progression of T2D, and how the latest treatment therapies can reduce the risk of serious complications.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/07/not-so-inevitable-type-2-diabetes-progression/" align="left"]
